Literature DB >> 17188055

Is early age-related macular degeneration associated with cerebral MRI changes? The Atherosclerosis Risk in Communities study.

Andrea Grosso1, Thomas H Mosley, Ronald Klein, David J Couper, Gabriella Tikellis, Tien Y Wong.   

Abstract

PURPOSE: To examine the relation of early age-related macular degeneration (AMD) with cerebral magnetic resonance imaging (MRI) changes.
DESIGN: Population-based, cross-sectional study.
METHODS: A sample of 1,684 persons ages 51 to 72 years with no history of stroke had cerebral MRI and retinal photography. MRI scans were graded for severity of white matter lesions (WML), sulcal widening (SW), and ventricular enlargement (VE). AMD was graded from retinal photographs.
RESULTS: After adjustment for age, gender, race, or center, early AMD (5.0% of participants) was not significantly associated with WML (odds ratio [OR] 1.0, 95% confidence intervals [CI], 0.6 to 1.6), SW (OR 0.6, 95% CI, 0.4 to 1.2), or VE (OR 1.0, 95% CI, 0.6 to 1.8).
CONCLUSIONS: These data showed no statistically significant association of early AMD with cerebral MRI changes, but the study was limited by a small number of cases with wide CIs. Further studies may clarify these associations.

Entities:  

Mesh:

Year:  2006        PMID: 17188055     DOI: 10.1016/j.ajo.2006.07.040

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  3 in total

1.  [Age-related macular degeneration and risk of stroke].

Authors:  V Biousse; M-G Bousser; A Gaudric
Journal:  J Fr Ophtalmol       Date:  2008-01       Impact factor: 0.818

2.  Functional Magnetic Resonance Imaging in Patients with the Wet Form of Age-Related Macular Degeneration.

Authors:  Jan Lešták; Jaroslav Tintěra; Ivan Karel; Zuzana Svatá; Pavel Rozsíval
Journal:  Neuroophthalmology       Date:  2013-09-24

3.  Risk factors for age-related maculopathy.

Authors:  Paul P Connell; Pearse A Keane; Evelyn C O'Neill; Rasha W Altaie; Edward Loane; Kumari Neelam; John M Nolan; Stephen Beatty
Journal:  J Ophthalmol       Date:  2009-09-06       Impact factor: 1.909

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.